| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bed23dd6f3c0c351cd3bfde9c1b11fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248d29aacbc09a65882479af9d8f0722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb606038660edc6f92a28ca673a5a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26593a7f6ddc79e1fd3f560c2ce19975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207772aca1ab092d5227d0eb155bf28f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e413e7b7aacaafc95fbe0a76ed792f3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f7d8034a39b42d3de4e0e1e5e230928 |
| publicationDate |
2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017337767-A1 |
| titleOfInvention |
Oral capsule composite formulation of dutasteride and tadalafil |
| priorityDate |
2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |